Clinical studies recruiting near Birmingham

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Flourish - Birmingham · AbbVie · NCT06602479 International Weight Control Registry
Phase N/A · University of Alabama at Birmingham · Tufts University · NCT04907396 Wavelength Intervention for Nearsighted Kids
NA · University of Alabama at Birmingham School of Optometry · University of Alabama at Birmingham · NCT06598423 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
Phase 1 · University of Alabama at Birmingham · University of Alabama at Birmingham · NCT06047886 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · University of Alabama Hospital · Joseph Broderick, MD · NCT07227246 Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
Phase 3 · Birmingham Childrens Hospital · Amgen · NCT04528082 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 31788, Alabama CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · Birmingham Children's Hospital · University of Birmingham · NCT05991388 Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Phase 2 · University of Alabama at Birmingham · Darcy Krueger · NCT05104983 Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
NA · University of Alabama · Duke University · NCT06906627 A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · Sleep Disorders Center of Alabama · Harmony Biosciences Management, Inc. · NCT07500090 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · University of Alabama at Birmingham Cancer Center · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Children's Hospital of Alabama · National Cancer Institute (NCI) · NCT05099003 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site - 8893 · Galderma R&D · NCT06988605 REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for
NA · University of Alabama at Birmingham · Duke University · NCT05218083 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Children's Hospital of Alabama · National Cancer Institute (NCI) · NCT06172296 VENTURI (VENTilation Using Respiratory Imaging)
Phase 2 · The University of Alabama at Birmingham · University of Alabama at Birmingham · NCT07282886 Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (
NA · Cardiology, P.C. · Biobeat Technologies Ltd. · NCT07240831 Methods of T Cell Depletion Trial (MoTD)
Phase 2 · Queen Elizabeth Hospital · University of Birmingham · NCT04888741 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Central Research Associates, LLC (CRA) dba Flourish Research · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · University of Alabama at Birmingham Cancer Center · NRG Oncology · NCT05624996 A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · The Kirklin Clinic of UAB Hospital · Pfizer · NCT07206225 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · University of Alabama at Birmingham · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC
Phase 2 · University of Alabama at Birmingham · Advenchen Pharmaceuticals, LLC. · NCT05363280 Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
Phase 1 · The University of Alabama at Birmingham · University of Alabama at Birmingham · NCT04332588 PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · University of Alabama at Birmingham · Duke University · NCT07232069 Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization
NA · University of Alabama at Birmingham · University of Alabama at Birmingham · NCT06565390 A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Ag
Phase 3 · Birmingham Women's and Children's NHS Foundation Trust · Travere Therapeutics, Inc. · NCT06247085 Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
Phase N/A · Birmingham Children's Hospital NHS Foundation Trust · Boston Children's Hospital · NCT03758521

Look up another city

Look up another condition